Moreover, RvD1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice, suggesting that RvD1 could provide a novel therapeutic strategy for treating obesity-induced diabetes (Hellmann et al., 2011). The gene discussed is INS; the disease is diabetes mellitus.